LIGAND PHARMACEUTICALS INCORPORATED Current State and Local Tax Expense (Benefit)
LIGAND PHARMACEUTICALS INCORPORATED (LGNXZ) reported Current State and Local Tax Expense (Benefit) of $280.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-02-27
- LIGAND PHARMACEUTICALS INCORPORATED current state and local tax expense (benefit) for fiscal 2025 was $280.00K, a 61.00% decline from fiscal 2024.
- LIGAND PHARMACEUTICALS INCORPORATED current state and local tax expense (benefit) for fiscal 2024 was $718.00K, a 229.36% increase from fiscal 2023.
- LIGAND PHARMACEUTICALS INCORPORATED current state and local tax expense (benefit) for fiscal 2023 was $218.00K, a 12.95% increase from fiscal 2022.
- LIGAND PHARMACEUTICALS INCORPORATED current state and local tax expense (benefit) for fiscal 2022 was $193.00K.
| Period end | Current State and Local Tax Expense (Benefit) 12 month | Current State and Local Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $280.00K 10-K · filed 2026-02-27 | |
| 2024-12-31 | $718.00K 10-K · filed 2026-02-27 | |
| 2023-12-31 | $218.00K 10-K · filed 2026-02-27 | |
| 2022-12-31 | $193.00K 10-K · filed 2025-02-28 | |
| 2021-12-31 | -$22.00K 10-K · filed 2024-02-29 | -$32.00K 10-K · filed 2022-02-28 |
| 2020-12-31 | $541.00K 10-K · filed 2023-02-28 | $589.00K 10-K · filed 2021-02-24 |
| 2019-12-31 | $3.10M 10-K · filed 2022-02-28 | |
| 2018-12-31 | $424.00K 10-K · filed 2021-02-24 | |
| 2017-12-31 | $111.00K 10-K · filed 2020-02-27 | |
| 2016-12-31 | $12.00K 10-K · filed 2019-02-28 | |
| 2015-12-31 | $7.00K 10-K · filed 2018-03-01 | |
| 2014-12-31 | $19.00K 10-K · filed 2017-02-28 | $33.00K 10-K · filed 2014-12-01 |
| 2013-12-31 | $33.00K 10-K · filed 2016-11-14 | |
| 2012-12-31 | $16.00K 10-K · filed 2015-02-23 | |
| 2011-12-31 | $139.00K 10-K/A · filed 2014-12-12 |